Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has issued an update.
ResMed Inc. has filed its quarterly report for the period ending December 31, 2024, indicating compliance with various regulatory requirements. The report highlights the company’s operational status, including financial performance and shareholder equity details, with no significant negative implications mentioned for stakeholders. The company continues to maintain its position as a large accelerated filer with a strong standing in the market.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc. operates within the healthcare industry, focusing on the development and manufacturing of medical devices related to sleep disorders, such as sleep apnea. The company is known for its innovative solutions and products that enhance patient care and improve quality of life. ResMed is a key player in the global market for sleep and respiratory care, providing equipment and services that address critical health needs.
YTD Price Performance: 9.27%
Average Trading Volume: 885,933
Technical Sentiment Consensus Rating: Sell
Current Market Cap: A$55.59B
See more data about RMD stock on TipRanks’ Stock Analysis page.
